Anticoagulant drugs that inhibit thrombin were shown to reduce the number of brain metastases in mouse models.
A global knockout of the thrombin receptor PAR1 accelerates myelin development. The findings could help with the development of treatments for diseases associated with demyelination, like multiple sclerosis.
Schwann cells help protect nerves against blood clotting factors that cause degeneration, researchers report.
Researchers devise a new molecular sensor which can detect multiple sclerosis at its earliest stage.
